Liquid biopsy is a non-invasive procedure which enables doctors to identify the information regarding the tumor using a blood sample. This technique is mainly used to diagnose chronic diseases such as cancer. It is also used to monitor the effect of treatment on cancer patients’ multiple times.

The global liquid biopsy market was valued at USD 730.2 million in 2018 and is expected to reach USD 2,028.5 million in 2026, growing at a CAGR of 22.8% during the forecast period.

The growth of the liquid biopsy market is primarily driven by increasing prevalence of cancer, growing adoption of non-invasive diagnostic and monitoring techniques and increasing preference of personalized medicines. In addition, technological advancement, increasing government initiatives to develop healthcare infrastructure and large availability funding’s for research and development for liquid biopsy is likely to contribute to the growth of liquid biopsy market during the forecast period.

Request for a Sample @ https://www.alltheresearch.com/sample-request/210

Key Players
The major players operating in the global liquid biopsy market are Bio-Rad Laboratories Inc. (US), Menarini Silicon Biosystems (Italy), Trovagene, Inc. (US),RainDance Technologies, Inc. (US), QIAGEN N.V. (Netherlands), Genomic Health, Inc. (US),Roche Diagnostics (US), Myriad Genetics, Inc. (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Guardant Health, Inc. (US), Biocept, Inc. (US), and MDx Health SA (US).among others.
On the other hand, uncertain reimbursement and regulation; and availability of alternative technique might hamper the liquid biopsy market to a certain extent throughout the forecast period.

Global Liquid Biopsy Market is Segmented by Product and Services, Circulating Biomarkers, Application and region.

By Product and Services: Assays kit, Instruments, Services

By Circulating Biomarkers: Circulating Tumor Cells, Circulating Tumor DNA, Cell-free DNA, Extracellular Vesicles, Others

By Application: Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring

Speak to Our Expert @ https://www.alltheresearch.com/speak-to-analyst/210

North America accounted for nearly 32% share of the global liquid biopsy market in 2018 and is expected to dominate the market throughout the forecast period followed by Europe. The growth of this region is attributed to the high incidence of cancer, easy accessibility and growing adoption of advanced diagnostic techniques. In addition, growing public and private funding to support research activities in the field of liquid biopsy contributes to the growth of this segment throughout the forecast periods.

ABOUT ALLTHERESEARCH:
AllTheResearch was formed with the aim of making market research a significant tool for managing breakthroughs in the industry. As a leading market research provider, the firm empowers its global clients with business-critical research solutions. The outcome of our study of numerous companies that rely on market research and consulting data for their decision-making made us realise, that it’s not just sheer data-points, but the right analysis that creates a difference.

FOR ALL YOUR RESEARCH NEEDS, REACH OUT TO US AT:
Email: [email protected]
Phone: 1-888-691-6870
Address: 39180 Liberty Street Suite 110, Fremont, CA 94538, USA